|
SCAMP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.063640E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.662300E-02 |
| Normal-vs-Stage2 |
9.836200E-01 |
| Normal-vs-Stage3 |
3.007900E-04 |
| Normal-vs-Stage4 |
3.9470999999569E-06 |
| Stage1-vs-Stage2 |
3.335400E-01 |
| Stage1-vs-Stage3 |
3.076500E-02 |
| Stage1-vs-Stage4 |
2.021000E-03 |
| Stage2-vs-Stage3 |
5.804200E-02 |
| Stage2-vs-Stage4 |
2.149500E-02 |
| Stage3-vs-Stage4 |
4.756400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.401200E-03 |
| Normal-vs-AfricanAmerican |
3.187500E-04 |
| Normal-vs-Asian |
3.125700E-02 |
| Caucasian-vs-AfricanAmerican |
1.010840E-01 |
| Caucasian-vs-Asian |
5.041400E-01 |
| AfricanAmerican-vs-Asian |
7.966600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.024200E-03 |
| Normal-vs-Female |
1.522270E-03 |
| Male-vs-Female |
6.063600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.12469999999465E-05 |
| Normal-vs-Age(41-60Yrs) |
1.240220E-02 |
| Normal-vs-Age(61-80Yrs) |
3.455500E-03 |
| Normal-vs-Age(81-100Yrs) |
7.996400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.458700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.818400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.357600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.181800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.420000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.612800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.699000E-01 |
| Normal-vs-Grade 2 |
2.115800E-01 |
| Normal-vs-Grade 3 |
1.950000E-04 |
| Normal-vs-Grade 4 |
9.48629996777584E-09 |
| Grade 1-vs-Grade 2 |
7.829200E-01 |
| Grade 1-vs-Grade 3 |
1.212850E-01 |
| Grade 1-vs-Grade 4 |
4.704500E-02 |
| Grade 2-vs-Grade 3 |
1.236140E-02 |
| Grade 2-vs-Grade 4 |
4.14609999999094E-06 |
| Grade 3-vs-Grade 4 |
6.536800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.774640E-01 |
| Normal-vs-ccB subtype |
3.137900E-02 |
| ccA subtype-vs-ccB subtype |
2.836200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.310400E-02 |
| Normal-vs-N1 |
6.643100E-04 |
| N0-vs-N1 |
3.641800E-02 |
|
|
